ETC-501 Is a Brain-Penetrant MNK Inhibitor That Potentiates TMZ-Induced Senescence and Sensitizes Glioblastoma Cells to Senolytic Therapy

Journal:

Cancer Research

Published:

2026-04-15

DOI:

10.1158/0008-5472.can-24-4388

Affiliations:

10

Authors:

16

Go to article

Institutions	Authors	Share
Duke-NUS Medical School, Singapore	4.583333	0.29
National Neuroscience Institute (NNI), Singapore	4.500000	0.28
Experimental Drug Development Centre (EDDC), A*STAR, Singapore	3.000000	0.19
Singapore General Hospital (SGH), Singapore	2.333333	0.15
National University of Singapore (NUS), Singapore	1.000000	0.06
Duke University Hospital, United States of America (USA)	0.333333	0.02
Singapore Health Services Pte. Ltd. (SingHealth), Singapore	0.250000	0.02

Interested in Oncology and Carcinogenesis?